DK2413954T3 - Sammensætning omfattende VIP eller dets aktive fragmenter til anvendelse ved behandling af aortafibrose - Google Patents

Sammensætning omfattende VIP eller dets aktive fragmenter til anvendelse ved behandling af aortafibrose

Info

Publication number
DK2413954T3
DK2413954T3 DK10757953.4T DK10757953T DK2413954T3 DK 2413954 T3 DK2413954 T3 DK 2413954T3 DK 10757953 T DK10757953 T DK 10757953T DK 2413954 T3 DK2413954 T3 DK 2413954T3
Authority
DK
Denmark
Prior art keywords
vip
treatment
composition
active fragments
aortic fibrosis
Prior art date
Application number
DK10757953.4T
Other languages
English (en)
Inventor
Karen Annette Duggan
Original Assignee
Vectus Biosystems Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901425A external-priority patent/AU2009901425A0/en
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Application granted granted Critical
Publication of DK2413954T3 publication Critical patent/DK2413954T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK10757953.4T 2009-04-02 2010-04-06 Sammensætning omfattende VIP eller dets aktive fragmenter til anvendelse ved behandling af aortafibrose DK2413954T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009901425A AU2009901425A0 (en) 2009-04-02 Compositions and methods for treatment of aortic fibrosis
PCT/AU2010/000391 WO2010111753A1 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis

Publications (1)

Publication Number Publication Date
DK2413954T3 true DK2413954T3 (da) 2014-05-12

Family

ID=42827427

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10757953.4T DK2413954T3 (da) 2009-04-02 2010-04-06 Sammensætning omfattende VIP eller dets aktive fragmenter til anvendelse ved behandling af aortafibrose

Country Status (18)

Country Link
US (2) US8729020B2 (da)
EP (1) EP2413954B1 (da)
JP (1) JP5687266B2 (da)
KR (1) KR101627008B1 (da)
CN (1) CN102711797A (da)
AU (1) AU2010230862B2 (da)
BR (1) BRPI1006748A2 (da)
CA (1) CA2757076C (da)
DK (1) DK2413954T3 (da)
ES (1) ES2462501T3 (da)
IL (1) IL215460A (da)
MX (1) MX2011010341A (da)
MY (1) MY180681A (da)
NZ (1) NZ595726A (da)
RU (1) RU2536223C2 (da)
SG (1) SG174966A1 (da)
WO (1) WO2010111753A1 (da)
ZA (1) ZA201107820B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006322656B2 (en) 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
WO2010042997A1 (en) * 2008-10-17 2010-04-22 Vectus Biosystems Pty Limited Compositions and methods for treatment of kidney disorders
EP2990027A1 (en) 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
CN104980999B (zh) * 2015-06-19 2017-03-08 广东欧珀移动通信有限公司 一种网络接入方法及移动终端
WO2024233903A1 (en) * 2023-05-11 2024-11-14 Wayne State University Combination treatments to promote epithelial integrity and treat ocular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043746A2 (en) * 2000-11-28 2002-06-06 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
EP1768689B1 (en) * 2004-06-11 2014-08-20 Vectus Biosystems Limited Compositions and methods for treatment of cardiovascular disease
AU2006322656B2 (en) * 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
JP2010538996A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 単独またはＴｈｒ−Ｔｈｒ−Ｓｅｒ−Ｇｌｎ−Ｖａｌ−Ａｒｇ−Ｐｒｏ−Ａｒｇ−ＯＨのペプチドとの組合せにおけるＡｓｎ−Ａｓｐ−Ａｓｐ−Ｃｙｓ−Ｇｌｕ−Ｌｅｕ−Ｃｙｓ−Ｖａｌ−Ａｓｎ−Ｖａｌ−Ａｌａ−Ｃｙｓ−Ｔｈｒ−Ｇｌｙ−Ｃｙｓ−Ｌｅｕ−ＯＨのペプチドの治療剤としての使用
WO2010042997A1 (en) * 2008-10-17 2010-04-22 Vectus Biosystems Pty Limited Compositions and methods for treatment of kidney disorders

Also Published As

Publication number Publication date
JP2012522727A (ja) 2012-09-27
EP2413954A1 (en) 2012-02-08
ES2462501T3 (es) 2014-05-23
US20120027850A1 (en) 2012-02-02
KR101627008B1 (ko) 2016-06-02
RU2536223C2 (ru) 2014-12-20
EP2413954B1 (en) 2014-02-26
US20140235541A1 (en) 2014-08-21
MX2011010341A (es) 2012-01-27
JP5687266B2 (ja) 2015-03-18
NZ595726A (en) 2013-06-28
CN102711797A (zh) 2012-10-03
AU2010230862A1 (en) 2011-11-03
WO2010111753A1 (en) 2010-10-07
MY180681A (en) 2020-12-06
CA2757076A1 (en) 2010-10-07
AU2010230862B2 (en) 2014-04-17
ZA201107820B (en) 2013-09-25
RU2011142268A (ru) 2013-05-10
CA2757076C (en) 2017-05-16
SG174966A1 (en) 2011-11-28
HK1165271A1 (en) 2012-10-05
IL215460A (en) 2017-01-31
BRPI1006748A2 (pt) 2018-03-06
KR20120024572A (ko) 2012-03-14
IL215460A0 (en) 2011-12-29
US8729020B2 (en) 2014-05-20
EP2413954A4 (en) 2012-11-21

Similar Documents

Publication Publication Date Title
DK3708178T3 (da) Peptid til brug ved forebyggelse eller behandling af makulær degenerering
DK2448637T3 (da) Anvendelse af ét fytocannabinoid eller en kombination af fytocannabinoider til behandling af epilepsi
SMT201400057B (it) Composizione per il trattamento della fibrosi cistica
BRPI1013335A2 (pt) composição compósita
IL216800A (en) Preparation for the treatment of dry eye syndrome
DK2475372T4 (da) Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse
DK2744456T3 (da) Forbedringer ved eller i forbindelse med proteser og ortoser
GB0807612D0 (en) New use of surfactant
DK3539540T3 (da) Sglt2-inhibitor 1-chlor-4-(beta-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzen i kombination med insulin til anvendelse i en fremgangsmåde til reduktion af risikoen for hypoglykæmi
EP2495255A4 (en) GLYCOSYLATED FORM OF AN ANTIGENIC GLP-1 ANALOG
EP2402032A4 (en) IMMUNOGENIC COMPOSITION
BRPI1006024A2 (pt) composição cosmética emulsificada
EP2416801A4 (en) IMMUNOGENIC COMPOSITION AND USES THEREOF
BR112012003152A2 (pt) composição removedora de oxigênio, artigo,e, uso de composição removedora de oxigênio.
BR112012008202A2 (pt) processo de preparação de uma composição, componentes e uso da composição
DK2435583T3 (da) miR-31 VED BEHANDLING AF DUCHENNES MUSKELDYSTROFI
DK3311810T3 (da) Anvendelse af sulcardin til behandling af atrieflimmer
IT1400374B1 (it) Procedimento per la realizzazione di un mattone in vetro e mattone ottenuto mediante detto procedimento
BR112014014724A8 (pt) composição líquida detergente, método de branquear por ar uma superfície e uso da combinação
BR112013033530A2 (pt) composição, e, uso de uma composição de tensoativo
PL2446196T3 (pl) Sposób dostarczania ciepła
DK2621517T4 (da) Sammensætning til anvendelse i behandlingen af infertilitet
BR112012012719A2 (pt) bactéria recombinante e processo para fabricar glicerol
EP2470197A4 (en) COMPOSITION FOR THE ABSORPTION AND DELAYED EFFECT OF LEPTIN PEPTIDES
FR2944820B1 (fr) Echafaudage demontable realise en materiau composite.